BioPharma Credit PLC (LON: BPCR)

BioPharma Credit Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 22, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	841	859	1,040	982	1,002	1,058
Market Cap Growth	-11.91%	-17.41%	5.90%	-2.00%	-5.28%	-7.83%
Enterprise Value	811	806	1,031	892	958	595
Last Close Price	0.71	0.59	0.62	0.50	0.47	0.46
PE Ratio	10.30	10.09	6.87	15.65	15.35	11.46
PS Ratio	8.26	8.06	5.74	12.80	12.44	9.29
PB Ratio	0.88	0.82	0.94	0.98	0.99	1.00
P/TBV Ratio	0.83	0.82	0.94	0.98	0.99	1.00
P/FCF Ratio	7.29	8.88	6.80	13.79	23.56	10.66
P/OCF Ratio	7.29	8.88	6.80	13.79	23.56	10.66
EV/Sales Ratio	7.44	7.56	5.70	11.62	11.88	5.23
EV/EBIT Ratio	9.28	9.46	6.82	14.21	14.66	6.45
EV/FCF Ratio	6.33	8.33	6.74	12.52	22.51	6.00
Asset Turnover	0.11	0.10	0.16	0.08	0.08	0.11
Quick Ratio	21.50	9.79	5.34	16.51	20.60	12.77
Current Ratio	21.50	9.79	5.34	16.51	20.60	12.77
Return on Equity (ROE)	8.56%	8.10%	13.50%	6.20%	6.41%	8.79%
Return on Assets (ROA)	5.33%	4.98%	8.33%	3.85%	3.96%	5.42%
Return on Capital (ROIC)	5.35%	5.06%	8.44%	3.87%	4.00%	5.49%
Earnings Yield	9.61%	9.91%	14.55%	6.39%	6.51%	8.73%
FCF Yield	13.71%	11.26%	14.70%	7.25%	4.24%	9.38%
Dividend Yield	11.19%	9.35%	9.30%	10.31%	10.80%	11.47%
Payout Ratio	119.60%	63.58%	52.52%	113.20%	107.89%	78.62%
Buyback Yield / Dilution	4.55%	4.00%	0.72%	0.00%	0.00%	-38.90%
Total Shareholder Return	15.74%	13.35%	10.02%	10.31%	10.80%	-27.43%

Source: S&P Capital IQ. Standard template. Financial Sources.